{"name": "Crescendo Biologics",
 "permalink": "crescendo-biologics",
 "crunchbase_url": "http://www.crunchbase.com/company/crescendo-biologics",
 "homepage_url": "http://www.crescendobiologics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@crescendobiologics.com",
 "phone_number": "+44 (0) 1223 497140",
 "description": "",
 "created_at": "Fri Jan 22 11:34:59 UTC 2010",
 "updated_at": "Wed Jan 05 21:44:19 UTC 2011",
 "overview": "\u003Cp\u003ECrescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.\u003C/p\u003E\n\n\u003Cp\u003EThe focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments that retain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       64],
      "assets/images/resized/0007/4444/74444v1-max-150x150.png"],
     [[220,
       95],
      "assets/images/resized/0007/4444/74444v1-max-250x250.png"],
     [[220,
       95],
      "assets/images/resized/0007/4444/74444v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Mike",
      "last_name": "Romanos",
      "permalink": "mike-romanos",
      "image": null}},
   {"is_past": false,
    "title": "Chairman",
    "person":
     {"first_name": "Graziano",
      "last_name": "Seghezzi",
      "permalink": "graziano-seghezzi",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$7.3M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/crescendo-biologics-ltd-series-a-73m/",
    "source_description": "Crescendo Biologics, Ltd.: Series A $7.3M",
    "raised_amount": 7300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 20,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sofinnova Ventures",
         "permalink": "sofinnova-ventures",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0003/0428/30428v1-max-150x150.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-250x250.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Avlar BioVentures",
         "permalink": "avlar-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0008/3732/83732v1-max-150x150.jpg"],
             [[177,
               84],
              "assets/images/resized/0008/3732/83732v1-max-250x250.jpg"],
             [[177,
               84],
              "assets/images/resized/0008/3732/83732v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Rainbow Seed Fund",
         "permalink": "rainbow-seed-fund",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0010/3114/103114v1-max-150x150.png"],
             [[194,
               64],
              "assets/images/resized/0010/3114/103114v1-max-250x250.png"],
             [[194,
               64],
              "assets/images/resized/0010/3114/103114v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Meditrina Building 260",
    "address2": "Babraham Research Campus",
    "zip_code": "CB22 3AT",
    "city": "Cambridge",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}